ACTRN12618001740280尚未招募不适用
Drug hypersensitivity reactions to direct acting hepatitis C virus antiviral drugs
Prof Michaela Lucas0 个研究点目标入组 108 人开始时间: 2018年10月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Diagnosis of drug hypersensitivity reaction (HSR) confirmed using:
- •Modified European Network of Drug Allergy (ENDA) drug allergy questionnaire.
- •Severe Cutaneous Adverse Reactions (SCAR) to drugs criteria.
- •Idiosyncratic drug-induced liver injury (iDILI) criteria.
- •Clinical severity.
- •Direct acting antiviral drug treatment at time of hypersensitivity reaction.
- •Laboratory parameters: liver function test, total bilirubin.
- •Informed consent for health information acquisition, DNA bio-sample (buccal swab).
排除标准
- •People under the age of 18years.
- •Females that are pregnant.
- •Those people not willing to give consent.
研究者
相似试验
尚未招募
不适用
Drug hypersensitivity study using a diagnosis algorithm to examinations of a suspected adverse drug reactioIn this study, we investigate drug hypersensitivity using a definitive diagnosis algorithm (modified Mirakian R. Clin Exp Allergy. 2009 Jan39:43-61.) to examinations of a suspected adverse drug reaction.JPRN-UMIN000026980Department of Pediatrics, Ehime University Hospital40
进行中（未招募）
不适用
In vitro evaluation of allergic reactions in hemophilia B subjects who have exhibited a systemic allergic response after exposure to BeneFIX (Nonacog Alfa; recombinant Factor IX) - Basophil Clinical StudyHemophilia BEUCTR2004-002648-88-DEWyeth Pharmaceuticals18
进行中（未招募）
不适用
In vitro evaluation of allergic reactions in hemophilia B subjects who have exhibited a systemic allergic response after exposure to BeneFIX (Nonacog Alfa; recombinant Factor IX)EUCTR2004-002648-88-FRWyeth Pharmaceuticals18
进行中（未招募）
1 期
In vitro evaluation of allergic reactions in hemophilia B subjects who have exhibited a systemic allergic response after exposure to BeneFIX (Nonacog Alfa; recombinant Factor IX) - Basophil Clinical StudyHemophilia BEUCTR2004-002648-88-GBWyeth Pharmaceuticals18
已完成
不适用
Patient´s awareness of a direct adverse drug reaction reporting system: an exploratory survey conducted at the Medical Center - University of Freiburg.Report of adverse drug reactions by patients.DRKS00007917niversitätsklinikum FreiburgStudienzentrum131